Journal article
Low-Molecular-Weight Heparin and Cancer Survival: Review of the Literature and Pooled Analysis of 1,726 Patients Treated for at Least Three Months
Abstract
BACKGROUND: Heparin has been the main subject of intensive investigation and clinical use because of its therapeutic anticoagulant properties. It also exhibits many other biological activities, and it was claimed that it shows a beneficial effect on cancer spreading. Searching for papers investigating the effect of low-molecular-weight heparin (LMWH) on cancer mortality we found clinical trials and meta-analyses which showed a reduction in the …
Authors
Conti S; Guercini F; Iorio A
Journal
Pathophysiology of Haemostasis and Thrombosis, Vol. 33, No. 4, pp. 197–201
Publisher
Karger Publishers
Publication Date
2003
DOI
10.1159/000081508
ISSN
1424-8832